United States Antimony Corporation Reports Record First Quarter 2025 Financial and Operating Results
- Revenue increased 128% YoY to $7 million
- Gross profit surged 302% YoY to $2.4 million
- Net income turned positive at $547k vs loss in Q1 2024
- Strong cash position of $18.7 million, up $6.8M YoY
- Antimony sales up 140% to $5.9 million
- Montana smelter expansion to increase capacity 6x
- Becoming the only fully integrated antimony company outside China
- Lower antimony sales volume due to contract and logistics delays
- Operating expenses increased by $954k to $2 million
Insights
UAMY shows exceptional financial turnaround with 128% revenue growth and shift to profitability driven by higher antimony prices and operational improvements.
USAC has delivered remarkable financial improvement across all key metrics in Q1 2025. Revenue jumped
The financial transformation stems primarily from antimony price increases rather than volume growth. Antimony sales of
The company maintains a strong liquidity position with
From an operational perspective, two major developments stand out: the April 2025 restart of the Madero Antimony Smelter in Mexico and the Montana smelter expansion that will increase throughput capacity sixfold by year-end. The Montana expansion will process feedstock from Alaska operations, where permitting is nearly complete.
USAC's strategic positioning as the only fully integrated antimony company outside China represents a significant competitive advantage in the critical minerals market. The zeolite division is also showing improved performance with increased volumes, better pricing, and reduced maintenance costs.
The combination of vastly improved financials, operational expansions, and strategic positioning in critical minerals creates a substantially stronger foundation than reflected in previous quarters.
Revenues Up
Gross Profit Up
Net Income Up
"The Critical Minerals and ZEO Company"
DALLAS, TX / ACCESS Newswire / May 8, 2025 / United States Antimony Corporation ("USAC" or the "Company" or "U.S. Antimony Corporation"), (NYSE:UAMY) reported today its first quarter 2025 financial and operational results.
Revenues for the first three months of 2025 increased
Our antimony sales were
The cash position of the Company at March 31, 2025 was
Commenting on the First Quarter 2025 financial and operational results, Mr. Gary C. Evans, Chairman and CEO of U.S. Antimony Corporation stated, "The improved financial results reported this quarter is due to continued higher price realizations for antimony and continued improved operating results from the zeolite division. BRZ experienced increased volumes and pricing along with less maintenance and related costs. With the restart in late April 2025 of the Madero Antimony Smelter located in Mexico, second quarter financial results should improve further. We recently announced our expansion plans at our antimony smelter in Montana last week on April 30, 2025. This expansion which is ongoing and to be completed prior to year-end, will improve throughput capacity at this facility by more than six times the current rate. This will be fueled primarily from our own feedstock originating out of Alaska. Our permitting phase in Alaska is almost complete and we are anxious to begin our gathering of antimony concentrate for shipment via trucks to Montana. Becoming the only fully integrated antimony company in the world, with the exception of China, gives us tremendous optionality and enhanced earnings capability. While this was another record quarter for the Company, we see continued improving financial and operational results for the ensuing quarters this year due to a combination of increased international shipments of antimony, higher zeolite volume commitments, increased pricing on both products, and continued improvements in operating efficiencies. We believe fiscal 2025 will continue to be an exciting and fruitful year for our shareholders as we ramp up operations in all areas of the Company."
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
For the Three Months Ended March 31, | ||||||||
2025 | 2024 | |||||||
REVENUES | $ | 7,000,005 | $ | 3,072,067 | ||||
COST OF REVENUES | 4,628,275 | 2,482,582 | ||||||
GROSS PROFIT | 2,371,730 | 589,485 | ||||||
OPERATING EXPENSES: | ||||||||
General and administrative | 550,595 | 500,286 | ||||||
Salaries and benefits | 1,000,555 | 241,605 | ||||||
Professional fees | 382,036 | 212,308 | ||||||
(Gain) loss on sale or disposal of property, plant and equipment, net | (500 | ) | 17,494 | |||||
Other operating expenses | 81,052 | 88,246 | ||||||
TOTAL OPERATING EXPENSES | 2,013,738 | 1,059,939 | ||||||
INCOME (LOSS) FROM OPERATIONS | 357,992 | (470,454 | ) | |||||
OTHER INCOME (EXPENSE): | ||||||||
Interest and investment income | 192,156 | 150,851 | ||||||
Trademark and licensing income | 10,843 | 6,368 | ||||||
Other miscellaneous expense | (14,467 | ) | (9,533 | ) | ||||
TOTAL OTHER INCOME, NET | 188,532 | 147,686 | ||||||
INCOME (LOSS) BEFORE INCOME TAXES | 546,524 | (322,768 | ) | |||||
Income tax expense | - | - | ||||||
Net income (loss) | 546,524 | (322,768 | ) | |||||
Preferred dividends | (1,875 | ) | (1,875 | ) | ||||
Net income (loss) available to common stockholders | $ | 544,649 | $ | (324,643 | ) | |||
Net income (loss) per share: | ||||||||
Basic | $nil | $nil | ||||||
Diluted | $nil | $nil | ||||||
Weighted average shares outstanding: | ||||||||
Basic | 113,703,415 | 107,908,306 | ||||||
Diluted | 122,298,290 | 107,908,306 | ||||||
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
March 31, 2025 | December 31, 2024 | |||||||
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
Cash and cash equivalents | $ | 18,746,429 | $ | 18,172,120 | ||||
Accounts receivable, net | 1,973,286 | 1,156,564 | ||||||
Inventories | 3,991,111 | 1,245,724 | ||||||
Prepaid expenses and other current assets | 127,589 | 104,161 | ||||||
Total current assets | 24,838,415 | 20,678,569 | ||||||
Property, plant and equipment, net | 13,471,988 | 12,891,447 | ||||||
Operating lease right-of-use assets | 410,573 | 565,289 | ||||||
Restricted cash for reclamation bonds | 99,290 | 98,778 | ||||||
IVA receivable and other assets, net | 676,512 | 408,519 | ||||||
Total assets | $ | 39,496,778 | $ | 34,642,602 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
CURRENT LIABILITIES | ||||||||
Accounts payable | $ | 3,206,080 | $ | 1,545,708 | ||||
Accrued liabilities | 613,159 | 1,427,146 | ||||||
Accrued liabilities - directors | 123,250 | 141,287 | ||||||
Royalties payable | 189,502 | 133,434 | ||||||
Current portion of operating lease liabilities | 452,826 | 626,562 | ||||||
Current portion of long-term debt | 133,409 | 132,252 | ||||||
Total current liabilities | 4,718,226 | 4,006,389 | ||||||
Operating lease liabilities, net of current portion | 294,989 | 129,007 | ||||||
Long-term debt, net of current portion | 161,636 | 195,425 | ||||||
Asset retirement obligations | 1,730,591 | 1,711,108 | ||||||
Total liabilities | 6,905,442 | 6,041,929 | ||||||
COMMITMENTS AND CONTINGENCIES | ||||||||
STOCKHOLDERS' EQUITY | ||||||||
Preferred stock | ||||||||
Series A - no shares issued and outstanding | - | - | ||||||
Series B - 750,000 shares issued and outstanding (liquidation preference | 7,500 | 7,500 | ||||||
Series C - 177,904 shares issued and outstanding (liquidation preference | 1,779 | 1,779 | ||||||
Series D - no shares issued and outstanding | - | - | ||||||
Common stock, | ||||||||
116,109,221 and 112,951,317 shares issued and outstanding, respectively | 1,161,092 | 1,129,512 | ||||||
Additional paid-in capital | 72,023,464 | 68,610,905 | ||||||
Accumulated deficit | (40,602,499 | ) | (41,149,023 | ) | ||||
Total stockholders' equity | 32,591,336 | 28,600,673 | ||||||
Total liabilities and stockholders' equity | $ | 39,496,778 | $ | 34,642,602 | ||||
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
For the three months ended March 31, | ||||||||
2025 | 2024 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net income (loss) | $ | 546,524 | $ | (322,768 | ) | |||
Adjustments to reconcile net income (loss) to | ||||||||
net cash provided by (used in) operating activities: | ||||||||
Depreciation and amortization | 281,970 | 106,147 | ||||||
Accretion of asset retirement obligation | 19,483 | 18,271 | ||||||
Noncash operating lease expense | 146,962 | - | ||||||
Share-based compensation | 245,384 | 205,925 | ||||||
(Gain) loss on sale or disposal of property, plant and equipment, net | (500 | ) | 17,494 | |||||
Write-down of inventory to net realizable value | - | 123,217 | ||||||
Other noncash items | - | (15,695 | ) | |||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | (816,722 | ) | (432,486 | ) | ||||
Inventories | (2,745,387 | ) | 394,772 | |||||
Prepaid expenses and other current assets | (23,428 | ) | (24,798 | ) | ||||
IVA receivable and other assets, net | (267,993 | ) | (34,989 | ) | ||||
Accounts payable | 1,660,372 | 84,250 | ||||||
Accrued liabilities | (813,987 | ) | 4,340 | |||||
Accrued liabilities - directors | (18,037 | ) | 42,249 | |||||
Royalties payable | 56,068 | (100,902 | ) | |||||
Net cash (used in) provided by operating activities | (1,729,291 | ) | 65,027 | |||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Proceeds from redemption of certificates of deposit | - | 50,682 | ||||||
Proceeds from sales of property, plant and equipment | 500 | - | ||||||
Purchases of property, plant and equipment | (862,511 | ) | (52,713 | ) | ||||
Net cash used in investing activities | (862,011 | ) | (2,031 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Principal payments on long-term debt | (32,632 | ) | (21,273 | ) | ||||
Proceeds from issuance of common stock, net of issuance costs | 2,392,317 | - | ||||||
Proceeds from exercise of warrants | 806,438 | - | ||||||
Net cash provided by (used in) financing activities | 3,166,123 | (21,273 | ) | |||||
NET INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH | 574,821 | 41,723 | ||||||
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD | 18,270,898 | 11,954,635 | ||||||
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD | $ | 18,845,719 | $ | 11,996,358 | ||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||||||||
Interest paid in cash | $ | 2,937 | $ | 651 | ||||
NON-CASH FINANCING AND INVESTING ACTIVITIES: | ||||||||
Noncash recognition of new operating leases | $ | 63,416 | - | |||||
About USAC:
United States Antimony Corporation and its subsidiaries in the U.S., Mexico, and Canada ("USAC," "U.S. Antimony," the "Company," "Our," "Us," or "We") sell antimony, zeolite, and precious metals primarily in the U.S. and Canada. The Company processes third party ore primarily into antimony oxide, antimony metal, antimony trisulfide, and precious metals at its facilities located in Montana and Mexico. Antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Antimony metal is used in bearings, storage batteries, and ordnance. Antimony trisulfide is used as a primer in ammunition. The Company also recovers precious metals, primarily gold and silver, at its Montana facility from third party ore. At its Bear River Zeolite ("BRZ") facility located in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, soil amendment and fertilizer, and other miscellaneous applications. The Company acquired mining claims and leases located in Alaska and Ontario, Canada and leased a metals concentration facility in Montana that could expand its operations as well as its product offerings.
Forward-Looking Statements:
Readers should note that, in addition to the historical information contained herein, this press release may contain forward-looking statements within the meaning of, and intended to be covered by, the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based upon current expectations and beliefs concerning future developments and their potential effects on the Company including matters related to the Company's operations, pending contracts and future revenues, financial performance and profitability, ability to execute on its increased production and installation schedules for planned capital expenditures, and the size of forecasted deposits. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent filings, including Form 10-K and Form 10-Q with the Securities and Exchange Commission.
Forward-looking statements are typically identified by words such as "believe," "expect," "anticipate," "intend," "outlook," "estimate," "forecast," "project," "pro forma," and other similar words and expressions. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made. Because forward-looking statements are subject to assumptions and uncertainties, actual results or future events could differ, possibly materially, from those anticipated in the forward-looking statements and future results could differ materially from historical performance.
CONTACT:
United States Antimony Corp.
4438 W. Lover's Lane, Unit 100
Dallas, TX 75209
Jonathan Miller, VP, Investor Relations
E-Mail: Jmiller@usantimony.com
Phone: 406-606-4117
SOURCE: United States Antimony Corp.
View the original press release on ACCESS Newswire
FAQ
What were UAMY's Q1 2025 financial results?
How much did UAMY's antimony sales grow in Q1 2025?
What is UAMY's cash position as of March 31, 2025?
What expansion plans did UAMY announce for its Montana facility?
How will UAMY become a fully integrated antimony company?
